Attached files

file filename
EX-5.1 - EXHIBIT 5.1 - DYAX CORPv371969_ex5-1.htm
EX-1.1 - EXHIBIT 1.1 - DYAX CORPv371969_ex1-1.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
 
WASHINGTON, D.C.  20549
 
FORM 8-K
 
 
CURRENT REPORT
 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 
Date of Report (Date of earliest event reported):  March 14, 2014
 
 
DYAX CORP.
(Exact Name of Registrant as Specified in Charter)
 
 
Delaware 000-24537 04-3053198  
(State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)  
       
 
55 Network Drive
Burlington, MA 01803
(Address of Principal Executive Offices)  (Zip Code)
 
 
(617) 225-2500
(Registrant's telephone number, including area code)
 
 
Not Applicable
(Former name or former address, if changed since last report)
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 1.01Entry into a Material Definitive Agreement.

 

On March 14, 2014, Dyax Corp. (the “Company”) entered into an Underwriting Agreement with Jefferies LLC, as representative of the several underwriters (the “Underwriting Agreement”), pursuant to which the Company agreed to offer and sell 8,000,000 shares of its common stock in an underwritten public offering at a public offering price of $9.25 per share. Pursuant to the terms of the Underwriting Agreement, the Company granted the underwriters a 30-day option to purchase up to an additional 1,200,000 shares. The Company expects to receive approximately $69.4 million in net proceeds from the offering after underwriting fees and offering expenses, or approximately $79.8 million if the underwriters’ option is exercised in full. The shares are expected to be delivered to the underwriters on or about March 19, 2014, subject to the satisfaction of customary closing conditions.

 

The common stock was registered for offer and sale on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”), by the Company’s Registration Statement on Form S-3 (Registration No. 333-192065) (the “Registration Statement”). Attached hereto as Exhibit 1.1 is a copy of the Underwriting Agreement. The opinion of the Company’s counsel regarding the validity of the shares issued pursuant to the offering is filed as Exhibit 5.1 hereto. This Current Report is being filed in part for the purpose of incorporating such exhibits by reference into the Registration Statement. In connection with this offering, on March 17, 2014, the Company filed with the Securities and Exchange Commission a prospectus supplement pursuant to Rule 424(b) under the Securities Act.

 

Item 9.01.Financial Statements and Exhibits.

 

(d)Exhibits.

 

1.1Underwriting Agreement between the Company and Jefferies LLC, as representative of the several underwriters, dated as of March 14, 2014.

 

5.1Opinion of Edwards Wildman Palmer LLP.

 

23.1Consent of Edwards Wildman Palmer LLP (contained in its opinion filed as Exhibit 5.1).

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    DYAX CORP.  
         
         
Dated: March 18, 2014      
    By: /s/ George Migausky  
      George Migausky,  
      Executive Vice President and Chief Financial  
      Officer  

 

 
 

 

Exhibits Index

 

Exhibit No.Description

 

1.1Underwriting Agreement between the Company and Jefferies LLC, as representative of the several underwriters, dated as of March 14, 2014.

 

5.1Opinion of Edwards Wildman Palmer LLP.

 

23.1Consent of Edwards Wildman Palmer LLP (contained in its opinion filed as Exhibit 5.1).